Introduction
Accretion/dilution analysis is the financial test that determines whether a bank deal "works" for the acquirer's shareholders. The basic question is simple: will the acquirer's EPS be higher (accretive) or lower (dilutive) after the deal than it would have been standalone? The answer is complex because bank mergers involve a set of earnings adjustments that do not exist in corporate M&A: core deposit intangible amortization, fair value marks on loan books, CECL model integration, and purchase accounting effects on both asset yields and liability costs. For FIG bankers, the accretion/dilution model is the deliverable that drives deal negotiations, and the nuances of how bank-specific adjustments flow through determine whether a deal receives board approval.
The Pro Forma EPS Calculation
The accretion/dilution formula is straightforward:
A positive result means the deal is accretive (shareholders are better off); negative means dilutive. The complexity lies in calculating pro forma EPS, which requires layering bank-specific adjustments onto the combined earnings base.
Pro Forma Net Income = Acquirer Net Income + Target Net Income + After-Tax Cost Savings - After-Tax Restructuring Charges - After-Tax CDI Amortization + After-Tax Fair Value Mark Accretion +/- Other Purchase Accounting Adjustments
Pro Forma Shares = Acquirer Shares Outstanding + New Shares Issued to Target Shareholders (exchange ratio times target shares)
- Accretion/Dilution in Bank M&A
In bank mergers, EPS accretion/dilution measures whether the combined entity generates higher per-share earnings than the acquirer would have achieved alone. The analysis incorporates bank-specific items that have no parallel in corporate deals: CDI amortization (a non-cash expense from the intangible value assigned to below-market deposits), fair value loan mark accretion (the accrual of purchase price discounts on acquired loans into net interest income), and the phased realization of cost savings (typically 50% in year one, 75% in year two, and 100% by year three). "Reported" accretion includes all GAAP adjustments. "Adjusted" or "operating" accretion excludes CDI amortization and restructuring charges, providing a cleaner view of the deal's economic impact. Both measures matter: reported accretion drives GAAP earnings per share, while adjusted accretion drives how analysts and investors evaluate the deal's true value creation.
The Key Adjustments
Cost Savings: The Primary Driver
Cost savings are the single largest accretion driver in most bank deals. They represent the permanent reduction in the combined entity's noninterest expense base from eliminating overlapping branches, consolidating back-office functions, and rationalizing technology platforms.
In-market deals (overlapping geographies) typically achieve 30-40% of the target's noninterest expense base. Inter-market deals (new geography entry) achieve 15-25%. SouthState's acquisition of Independent Bank Group projected 25% of Independent's expense base. Capital One projected $1.5 billion in expense synergies from the Discover acquisition plus an additional $1.2 billion in network synergies.
Cost savings phase in over 2-3 years, which means accretion improves annually:
| Year | Typical Cost Save Realization | Impact on Accretion |
|---|---|---|
| Year 1 | ~50% | Modest accretion (offset by integration costs) |
| Year 2 | ~75% | Stronger accretion (integration costs declining) |
| Year 3+ | 100% | Full run-rate accretion |
This phase-in explains why Pinnacle-Synovus projected 21% EPS accretion "by 2027" (two years post-close, when full synergies are realized) rather than quoting a year-one number. The year-one accretion is typically much lower or even negative after integration costs.
CDI Amortization: The Non-Cash Drag
CDI amortization reduces reported earnings by the annual amortization charge (CDI value divided by useful life, typically 10 years, often on an accelerated schedule). A $200 million CDI amortized over 10 years creates approximately $20 million per year in additional noninterest expense, directly reducing GAAP EPS.
Analysts universally add CDI amortization back when calculating "adjusted" or "operating" accretion because it is a non-cash expense that represents the accounting recognition of a real economic benefit (below-market funding). The deposit franchise continues to generate the cost savings that CDI was designed to capture; the amortization simply reflects the accounting consumption of the intangible over time.
The distinction between reported and adjusted accretion matters for deal communication. A deal might be 5% dilutive on a reported basis (after CDI amortization and restructuring charges) but 15% accretive on an adjusted basis (excluding those items). Management teams typically emphasize the adjusted figure; investors evaluate both.
Fair Value Loan Mark Accretion: The Temporary Boost
When a bank acquires another bank, all loans in the target's portfolio are marked to fair value at closing. Loans originated at rates below current market rates receive a discount to carrying value. This discount is then accreted back into net interest income over the remaining lives of the loans (typically 3-7 years), creating a "purchased loan accretion" benefit that boosts NII and earnings.
The Accretion-TBV Dilution Trade-Off
The central tension in bank deal analysis is the trade-off between EPS accretion (good for current earnings) and TBV dilution (bad for book value). Every premium paid above tangible book value creates goodwill that dilutes TBV per share. But the cost savings and earnings from the acquired franchise drive EPS accretion. Higher premiums create more TBV dilution but can still be accretive if the target's earnings and synergies are large enough relative to the shares issued.
The three recent mega-deals illustrate different positions on this spectrum:
| Deal | EPS Accretion | TBV Dilution | TBV Earn-Back |
|---|---|---|---|
| SouthState-Independent | 27% | 9.6% | 2 years |
| Pinnacle-Synovus | 21% (by 2027) | Moderate | 2.6 years |
| Fifth Third-Comerica | Immediately accretive | 0% (zero) | N/A |
Fifth Third-Comerica represents the ideal outcome: immediate EPS accretion with zero day-one TBV dilution. This was achievable because the deal premium was moderate (20% to VWAP at 175% of TBV), Comerica's profitability was strong, and expected synergies were substantial. SouthState-Independent represents a more typical outcome: strong EPS accretion (27%) but meaningful TBV dilution (9.6%), with the market accepting the dilution because the 2-year earn-back is well within the standard.
Why Bank Accretion/Dilution Is More Complex Than Corporate M&A
In corporate M&A, the accretion model requires a purchase price, financing assumptions (debt vs. equity vs. cash), target earnings, and synergies. In bank M&A, the model must also incorporate:
- CDI valuation and amortization: An entire intangible asset class unique to banking that requires independent appraisal and creates a multi-year earnings drag
- Fair value marks on the entire loan book: Detailed credit analysis of every loan category, producing both credit marks and rate marks that accrete over 3-7 years
- CECL model integration: The acquirer must integrate the target's credit loss expectations into its own expected loss model, affecting day-one reserve levels and future provision expense
- Deposit decay assumptions: Core deposits have no fixed maturity; the model must project deposit runoff rates by product type and rate environment
- [Regulatory capital constraints](/guides/fig-investment-banking/goodwill-impact-regulatory-capital): Pro forma CET1 ratios must clear the requirement plus management buffer; if the deal pushes CET1 too low, it cannot proceed regardless of how accretive it is
- Balance sheet re-marks: Unlike corporate deals where only specific assets are fair-valued, bank acquisitions require fair value adjustments across the entire balance sheet (loans, securities, deposits, borrowings)
These layers of complexity mean that a bank merger model is typically twice the size of a comparable corporate merger model, and the judgment calls (deposit decay rates, CDI useful life, loan mark accretion schedules, cost save timing) are more numerous and more consequential.
Accretion/dilution analysis is the quantitative test that determines whether a bank deal creates or destroys shareholder value. It is the model that acquirer boards review before authorizing a bid, the metric that analysts update when stress test results change capital positions, and the framework through which the market evaluates every bank merger announcement. Mastering its bank-specific mechanics is non-negotiable for FIG professionals.


